A Semi-mechanistic Model for the Effects of a Novel Glucagon Receptor Antagonist on Glucagon and the Interaction Between Glucose, Glucagon, and Insulin Applied to Adaptive Phase II Design

A potent novel compound (MK-3577) was developed for the treatment of type 2 diabetes mellitus (T2DM) through blocking the glucagon receptor. A semi-mechanistic model was developed to describe the drug effect on glucagon and the interaction between glucagon, insulin, and glucose in healthy subjects (...

Full description

Saved in:
Bibliographic Details
Published in:AAPS J
Main Authors: Peng, Joanna Z., Denney, William S., Musser, Bret J., Liu, Rong, Tsai, Kuenhi, Fang, Lanyan, Reitman, Marc L., Troyer, Matthew D., Engel, Samuel S., Xu, Lei, Stoch, Aubrey, Stone, Julie A., Kowalski, Ken G.
Format: Artigo
Language:Inglês
Published: Springer US 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389739/
https://ncbi.nlm.nih.gov/pubmed/25160589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-014-9648-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items